Moderna, Inc. 4

Director Michael R. McDonnell received stock option and RSU equity awards in Moderna, Inc. as part of his compensation, with no open-market buys or sells reported.

On July 8, 2026, Moderna director Michael R. McDonnell received a grant of stock options for 7,415 shares of common stock with an exercise price of $73.80 per share, vesting fully on July 8, 2027, along with two separate restricted stock unit (RSU) awards for 1,618 shares and 5,733 shares of common stock, each converting into common stock on a one-for-one basis and vesting in full on specified future dates (the earlier of May 6, 2027, or Moderna's next Annual Meeting of Stockholders for one award, and July 8, 2027 for the other); these are non-cash, equity-based compensation awards, and no open-market purchases or sales occurred in this filing.

Filing Facts

CIK

1682852

Ticker

MRNA

Form

4

Source Type

fda

Accession

0001682852-26-000139

Alert Tier

5